Search Icon
SideMenu
Home
Press Releases

Press Releases
  • Press Releases

Patent Thickets and Litigation Abuses Hinder all Biosimilars
  • Press Releases

Groups Join the Biosimilars Council and AAM Letter of Support for Interchangeability Legislation
  • Press Releases

Mark Ratner Joins AAM to Lead Government Relations
  • Press Releases

Hikma Breaks Ground on Expanded U.S. Manufacturing and Announces $1 Billion Investment
  • Press Releases

Eighth Circuit Court Rules Unanimously for AAM in Generic Pricing Appeal
  • Press Releases

Generic and Biosimilar Patent Settlements Save $423 Billion
  • Press Releases

AAM Comments on Section 232 Investigation on Pharmaceuticals
  • Press Releases

AAM Commends Senate Q1/Q2 Bill Introduction
  • Press Releases

AAM Congratulates Dr. Oz on Confirmation as Administrator of the Centers for Medicare & Medicaid Services
  • Press Releases

AAM Comments on staff layoffs at FDA
  • Press Releases

AAM Congratulates FDA Commissioner Makary
  • Press Releases

AAM Commends Q1/Q2 House Bill Reintroduction
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2025 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram